Boronic acid derivatives
Cayman Chemical CAY10602 Fatty Acids and Deriv
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells at 20 and 60 µM; decreases the expression of GPX4, SLC7A11, and SLC3A2, as well as increases the levels of iron and MDA, in A549, MDA-MB-231, and Hs 578T cells at 5 µM; reduces oleic acid-induced apoptosis and lipid accumulation in HepG2 cells when used at a concentration of 20 µM
Cayman Chemical CAY10602 Fatty Acids and Deriv
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells at 20 and 60 µM; decreases the expression of GPX4, SLC7A11, and SLC3A2, as well as increases the levels of iron and MDA, in A549, MDA-MB-231, and Hs 578T cells at 5 µM; reduces oleic acid-induced apoptosis and lipid accumulation in HepG2 cells when used at a concentration of 20 µM
Cayman Chemical CAY10602 Fatty Acids and Deriv
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells at 20 and 60 µM; decreases the expression of GPX4, SLC7A11, and SLC3A2, as well as increases the levels of iron and MDA, in A549, MDA-MB-231, and Hs 578T cells at 5 µM; reduces oleic acid-induced apoptosis and lipid accumulation in HepG2 cells when used at a concentration of 20 µM
Cayman Chemical CAY10602 Fatty Acids and Deriv
A SIRT1 activator; inhibits LPS-induced TNF-α release in THP-1 cells at 20 and 60 µM; decreases the expression of GPX4, SLC7A11, and SLC3A2, as well as increases the levels of iron and MDA, in A549, MDA-MB-231, and Hs 578T cells at 5 µM; reduces oleic acid-induced apoptosis and lipid accumulation in HepG2 cells when used at a concentration of 20 µM